While public financing for private biotechnology companies has been severely affected by the economic downturn, deal dynamics for collaborations and licensing transactions have also been impacted, providing insight into key considerations for the negotiation of collaboration and licensing agreements in a volatile environment.
In a Bloomberg Law article, life sciences partner Abigail Gregor and intellectual property transactions associate Georgina Jones Suzuki analyze deal process and transaction structures, economics, research and development programs, and insolvency matters with the aim to provide attorneys and business development professionals in the life sciences industry with the tools to identify creative solutions and close deals.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.